ABSTRACT
In ANCA-associated vasculitis (AAV), experimental data indicate that both humoral and cellular arms of the immune system mediate glomerular injury. In experimental models, antimyeloperoxidase (anti-MPO) antibodies activate neutrophils and mediate neutrophilmediated glomerular injury. 1, 2 In humans 3 and mice, 4 this process results in MPO deposition in the glomerulus. Thus, ANCA-activated neutrophils not only induce injury, but also, they deposit the autoantigen MPO within the target tissue, the kidney. Although experimental evidence shows that MPO peptides can be recognized by MPO-specific CD4 + T cells that effect injury, 4 several lines of evidence implicate CD8 + cells in AAV. The proportion of activated CD8 + cells is increased in the blood of patients with AAV, including an expanded population of CD8 + CD28 + CD11b + cells that can produce IFN-g. [5] [6] [7] In the kidney, CD8
+ cells are at least as common as CD4 + cells, 3, 8 and their numbers correlate with lower patient eGFR at presentation. 3 Furthermore, an active, nonexhausted CD8 + T cell phenotype is a marker of poor prognosis in AAV, identifying patients who suffer disease relapses. 9, 10 However, there are no experimental studies confirming an injurious role for CD8 + cells in ANCA-associated GN.
CD8 + T cells recognize peptides presented by MHC class I. They can kill cells via perforin and granzymes and also, secrete cytokines, including IFN-g and TNF, that have effects on tissue cells and immune cells. 11 In addition to their function in host defense, CD8
+ cells have been defined as key mediators of autoimmune diseases. 12 To determine the role of CD8 + T cells as effectors of glomerular injury in experimental AAV, we depleted CD8 + T cells using an antiCD8b mAb in experimental murine autoimmune anti-MPO GN. Injury in this model involves inducing anti-MPO autoimmunity in mice. Although anti-MPO antibodies are present in this model, they are insufficient to induce disease, and therefore, disease is triggered by recruiting neutrophils to glomeruli with low-dose sheep anti-mouse glomerular basement membrane (GBM) antibodies ( Figure 1A) . In these models, recruited neutrophils deposit the autoantigen, MPO, in glomerular capillaries, allowing MPO to be recognized locally by effector T cells. 4, 13 CD8 + cell depletion efficiency in the circulation was .90% at the time of trigger (Supplemental Figure 1A) , and as anticipated, humoral autoimmunity (anti-MPO IgG levels) was unaffected (Supplemental Figure  1B) . CD8 + T cell intact mice developed albuminuria and focal proliferative GN, with areas of segmental necrosis. Depletion of CD8 + T cells attenuated albuminuria ( Figure 1B) , whereas BUN was not elevated in this model ( Figure 1C ). CD8 + cell depletion also limited histologic injury ( Figure 1D ). Infiltrating glomerular CD8 + T cells were not present after depletion ( Figure 1E ), and, glomerular CD4 + T cells and macrophages (but not neutrophils) were also reduced ( Figure 1 , F-H). Depletion of CD8 + T cells reduced the intrarenal CD8 + T cell cytokines IFN-g and TNF as well as the IFNg-inducible chemokines CXCL9 and CXCL10. There was a trend to decreased CCL20 and CCL2 ( Figure 1H ), whereas CXCL1 and CCL5 were not increased at this time point in this model (Supplemental Figure 1 , C and D). Interstitial cellular infiltrates showed fewer CD8 + T cells, with a trend toward fewer macrophages in CD8 + cell depleted mice (P=0.07), but interstitial CD4 + T cells and neutrophils were not elevated at this stage of disease (Supplemental Figure 1 , E-H).
When we enumerated the numbers of infiltrating CD8 + T cells and determined the phenotype of the intrarenal CD8 + T cells, we found an increase in the number of intrarenal CD8 + T cells in disease (Supplemental Figure 2A) , in particular, CD8 + T cells that made IFN-g and TNF but not Granzyme B (Supplemental Figure  2B ). In the spleen, after MPO or ovalbumin (OVA) immunization, as expected, numbers of CD8 + T cells increased (Supplemental Figure 2C ), including increases in the proportions of IFN-g-and TNF-expressing cells (Supplemental Figure 2D ). This increase, compared with that in OVAimmunized control mice, shows that proinflammatory CD8 + T cells infiltrate (Figure 2A ). To determine the immunogenicity of these epitopes in vivo, the expansion of epitope-specific CD8 + T cells was quantified by enumerating the numbers of epitope-specific CD8 + T cells in spleen and lymph nodes of mice using pMHCI dextramers before and after immunization with either 431 Figure 2 , B-F). For the 431 ITYRDYLPL 439 epitope alone, this represents $600 cells in secondary lymphoid organs. In autoimmune disease, autoreactive effector T cells localize to sites of inflammation and may represent a significant proportion of the approximately 10,000 excess intrarenal CD8 + cells found in this model (Supplemental Figure 2A) .
On the basis of the increased immunogenicity of the 431 ITYRDYLPL 439 peptide (equivalent to the human sequence 457 ITYRDYLPL 465 ), we generated CD8 + T cell clones specific for 431 ITYRDYLPL 439 . To confirm that the generated CD8 + T cell clone was specific for 431 ITYRDYLPL 439 , we performed a granzyme B release assay and showed that coculture of the CD8 + T cell clones induced granzyme B release only when cocultured with its cognate peptide and not in the presence of a control peptide ( Figure 2G ). Clones were IL-2 dependent and expressed the IL-7Ra (data not shown).
We have previously shown that the transfer of MPO-specific CD4 + T cells into Rag1 2/2 mice (deficient in both T and B cells) caused focal necrotizing GN after MPO was deposited in glomeruli. 4 To determine if MPO-specific CD8 + T cells could augment CD4 + T cellmediated injury, we cotransferred low doses on the basis of a dose that was one half the number of cells transferred in our previously published models 4 Figure  3, B-D) . The MPO-specific CD8 + T cell clones' accumulation within glomeruli ( Figure 3E ) was accompanied by more glomerular macrophages ( Figure 3F ). Numbers of glomerular infiltrating CD4 + T cells and neutrophils were similar between the groups (Figure 3, (Figure 4 , B-D) with more infiltrating CD8 + T cells and macrophages compared with mice receiving control CD8 + T cells ( Figure 4 , E and F). Neutrophil numbers were similar between groups ( Figure 4G ). Therefore, even in the absence of CD4 + T cells, effector MPO-specific CD8 + T cells can infiltrate the glomerulus and mediate glomerular injury when MPO is lodged in the glomerulus.
In these CD8 + T cell clone transfer experiments, MPO-specific CD8 + T cells accumulate in the kidney when MPO is deposited in glomeruli. Therefore, CD8 18 and that crosspresentation to CD8 + cells occurs in endothelial cells 19 and podocytes. 20 In humans, it is likely that MPO-ANCA-mediated neutrophil activation induces glomerular neutrophil recruitment and local release of MPO.
The human disease-associated B cell epitope, 421 RKIVGAMVQIITY 433 (subscripts indicate mouse amino acid numbering), overlaps with the nephritogenic CD8 + T cell epitope identified in this study, 431 ITYRDYLPL 439 (bold letters are overlapping sequences). 4, 21 Furthermore, it is adjacent to the immunodominant murine CD4 + T cell epitope, 409 PRWNGEKLYQEARKIVGAMV 428 . 4 This indicates that there may be an immunogenic hotspot within the MPO molecule that could be exploited for peptide-based or antigen-specific tolerogenic therapies. For example, mucosal tolerance using a single peptide spanning the CD4 + and CD8 + T cell epitopes and the B cell epitope could plausibly affect all three key immune cell types in AAV, which has been shown experimentally for anti-MPO CD4 + cells. 22 However, we note that our MPO CD8 + cell epitopes are candidate epitopes that serve as proof of concept that MPO-specific CD8 + cells can induce injury, which is shown in our studies.
The results in this study are concordant with observations in other models of autoimmune disease, including diabetes, arthritis, and anti-GBM disease, using depleting anti-CD8 mAbs [23] [24] [25] as well as experimental autoimmune encephalomyelitis, which showed that the transferred myelin-specific CD8 + T cells induce disease. 26 Collectively, these studies support observations in patients with AAV, 3, [8] [9] [10] providing functional To detect intrarenal expression of cytokines and chemokines, RNA was extracted from whole kidney in Trizol (Thermo Fisher Scientific, Vernon Hills, IL ), treated with 1 U DNase I (Thermo Fisher Scientific), primed with random primers (Thermo Fisher Scientific), and reversed transcribed using the High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific). Gene-specific amplification was performed using either TaqMan Gene Expression Assays (Thermo Fisher Scientific) or custom oligonucleotide primers designed using the Primer 3 software (Whitehead Institute for Biomedical Research, Cambridge, MA), standardized to 18S, and expressed as relative quantification compared with control mice immunized with OVA using the DDCT method. Serum anti-MPO IgG antibodies were measured by ELISA at a serum dilution of 1:4000.
CONCISE METHODS

Experimental
Enumeration and Characterization of CD8 + T Cells by Flow Cytometry
Cell isolation was performed as previously described. 27, 28 Kidneys were digested with 5 mg/ml collagenase D (Roche Diagnostics, Indianapolis, IN) and 100 mg/ml DNase I (Roche Diagnostics) in HBBS (Sigma-Aldrich, St. Louis, MO) for 30 minutes at 37°C. Cells were filtered, erythrocytes were lysed, and the CD45 + leukocyte population was isolated using mouse CD45 microbeads (Miltenyi Biotec, San Diego, CA). For IFN-g and TNF intracellular cytokine staining, CD45 + -enriched renal cells were activated by incubation with 50 ng/ml PMA (Sigma-Aldrich), 1 mg/ml ionomycin (Sigma-Aldrich), and 10 mg/ml brefeldin A (Sigma-Aldrich) in RPMI complete medium (Gibco, Carlsbad, CA) for 3 hours at 37°C and 5% CO 2 . Cells were stained with anti-mouse CD45 (Pacific Blue; 30-F11; BioLegend, San Diego, CA) and anti-mouse CD8 (APCeFlour780; 53-6.7; eBioscience). Intracellular cytokine staining was performed using the Foxp3/Transcription Factor Fixation/ Permeabilization Kit as per the manufacturer's protocol (eBioscience). Cells were stained with anti-mouse IFN-g (PE; XMG1.2; BD Biosciences, San Jose, CA), anti-mouse TNF (PE; MP6-XT22; BD Biosciences), and antimouse Granzyme B (PerCP-eFluor710; NGZB; eBioscience). Cells were suspended with 10 ml SPHERO AccuCount Particles (1000 beads per microliter; Spherotech, Lake Forest, IL), and 1000 beads were acquired on the FACSCanto II Instrument using FACSDiva software, version 6. cytometric data were analyzed using FlowJo software, version 8.8.6 (TreeStar, Inc., Ashland, OR).
Generation of MPO-Specific CD8 + T Cell Clones
Peptides predicted to bind to mouse H2-K b (Supplemental Table 1 ) were synthesized at a purity of .95% (Mimotopes, Notting Hill, Victoria, Australia). The ability of the peptides to induce a CD8 + T cell cytotoxic response was determined using a JAM assay. 29 Effector T cells were generated by priming C57BL/6 WT mice in vivo by subcutaneous injection in the base of tail with 100 mg glomerular segmental necrosis (periodic acid-Schiff-stained micrographs show segmental necrosis in mice that received MPO-specific CD8 + T cell clones); and infiltration of (E) CD8 + T cells, (F) macrophages, and (G) neutrophils (DAB Brown-stained micrographs depict illustrative examples of glomerular infiltration of the respective cell type). All bar graphs represent means6 SEMs of n=4-6 per group. gcs, Glomerular cross-section. *P,0.05 by ANOVA; **P,0.01 by ANOVA. cells, and 10 ng/ml IL-2 in complete DMEM-20 (Thermo Fisher Scientific). To determine antigen specificity, CD8 + T cell clones were cultured in the presence of target cells (EL4) and media alone, 431 ITYRDYLPL 439 , or SIINFEKL for 4 hours at 37°C. Granzyme B activity was measured spectrophotometrically using N-a-benzyloxycarbonyl-L-lysine thiobenzyl ester and 5,59-dithio-bis(2-nitrobenzoic acid) and expressed as a percentage of maximum release relative to Triton X lysed cells. 32
Statistical Analyses
An unpaired t test was used to analyze the difference between two groups, and a one-way ANOVA was used when there were more than two groups using GraphPad Prism Software (GraphPad Software Inc., San Diego, CA). A P value of ,0.05 was considered a statistically significant difference. Data are expressed as means6SEMs.
